62 results
PRE 14A
fmteup4h5ptm6977gpu8
28 Mar 24
Preliminary proxy
4:36pm
S-3ASR
grpa6892z
12 Mar 24
Automatic shelf registration
4:45pm
S-3ASR
EX-4.5
semyrq7w1wjwp 3ch4tc
12 Mar 24
Automatic shelf registration
4:45pm
8-K
EX-99.2
okn51v4
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
424B5
a2sze
4 Jan 24
Prospectus supplement for primary offering
4:48pm
424B5
khdfuu wueb6v
2 Jan 24
Prospectus supplement for primary offering
4:54pm
8-K
EX-99.2
zkfzfu
2 Jan 24
Regulation FD Disclosure
9:44am
8-K
EX-99.1
p58z6v2s r9swxxu24
29 Nov 23
Regulation FD Disclosure
8:35am
8-K
EX-99.1
6c1gd3a4z8x aw0h21u6
11 Oct 23
Regulation FD Disclosure
9:26am
8-K
EX-3.1
k41 utyvtb3av6h7azx
22 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:21pm
8-K
EX-99.1
1rlq1og y63n1k
23 Aug 23
Enrolled 52 participants with Developmental and Epileptic Encephalopathies (DEEs) into the PACIFIC Study
8:46am